A total of 778 blood samples collected from Palestinian subjects between September 1989 and March 1990 were tested for hepatitis B surface antigen (HBsAg) and when negative for antibody to hepatitis B surface antigen (anti-HBs). The emphasis of the survey was on the younger population with 85% of those tested under the age of 30 years. The prevalence of positive markers (HBsAg or anti-HBs) rose progressively with age, being 1% under the age of 5 years and reaching 47% in those aged between 30 and 50 years. The results clearly show that this infection is endemic in our population. A vaccination policy is discussed. The most important finding was the very low prevalence of the infection in those under 5 years of age, indicating the minor role played by perinatal transmission in our community. Thus, an effective immunization programme does not need to target newborns.
No takes yet. Share an insight, caveat, or question.
Nashef et al. (1992) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: